Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Claims 1, 3-12, 21-24 and 28 are pending.
The indicated allowability of claims 21-22 is withdrawn in view of Palmer et al. WO 2017/030876 2/23/2017 cited previously.
Claim Rejections - 35 USC § 102
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claim(s) 21-22 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Palmer et al. WO 2017/030876 2/23/2017 cited previously.
Claim 21: Palmer et al disclose a system (paragraph 11) for forming a gel on targeted surfaces of groups of chicks, wherein the targeted surface is the chicks down (paragraph 5, 8, 13) comprising:
a first delivery device (independent nozzle) in fluid communication with a first vessel containing a binding agent (alginic crosslinking solution), the first delivery device having a first delivery device outlet (mouth of the nozzle);
and a second delivery device (nozzle on manifold) in fluid communication with a second vessel containing a gelling component (alginic acid gel), the second delivery device having a second delivery device outlet (mouth of the nozzle on the manifold)
wherein the system is configured to form gels on the down of the chicks (targeted surface of a group of animals) via a method comprising:
moving the first solution from the first vessel to the first delivery device outlet to create a first spray toward the groups of chicks, and
moving the second solution from the second vessel to the second delivery device outlet to create towards the chicks, so that the first and second solutions react to form a gel on the targeted surface (downs) of the chicks,
wherein gels formed on the down of group of animals are configured to be absorbed by respective mucosa of the chicks i.e. the chicks are placed closely together so they can consume the gel of each other’s down, thus orally absorbing the gel. See paragraphs 4, 5, 10-14.
Claim 22: Palmer et al disclose the first or second solution comprises a product of interest such as vaccine, medication, nutrients, vitamins, probiotics, protein, fat, and prebiotics
Status of Claims
Claims 1, 3-12, 23-24 and 28 are allowed. Claims 21-22 are rejected.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to OLUWATOSIN A OGUNBIYI whose telephone number is (571)272-9939. The examiner can normally be reached IFP.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Daniel Kolker can be reached at 5712723181. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/OLUWATOSIN A OGUNBIYI/ Primary Examiner, Art Unit 1645
Prosecution Insights